Page last updated: 2024-08-16

sumatriptan and tonabersat

sumatriptan has been researched along with tonabersat in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	6 (75.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, WN; Evans, JM; Hadley, MS; Herdon, HJ; Jerman, JC; Parsons, AA; Read, SJ; Stean, TO; Thompson, M; Upton, N	1
de Vries, R; MaassenVanDenBrink, A; Parsons, AA; Saxena, PR; Upton, N; van den Broek, RW	1
Hirst, WD; Parsons, AA; Read, SJ; Upton, N	1
Bockhorst, KH; Bradley, DP; Hall, LD; Huang, CL; James, MF; Leslie, RA; Netsiri, C; Parsons, AA; Smith, JM; Smith, MI	1
Bradley, DP; Hall, LD; Huang, CL; James, MF; Netsiri, C; Papadakis, N; Parsons, AA; Smith, MI; Takeda, T	1
Unger, J	1
Dahlöf, CG; Hauge, AW; Olesen, J	1
Ashina, M; Olesen, J	1

Reviews

2 review(s) available for sumatriptan and tonabersat

Article	Year
Migraine headaches: a historical prospective, a glimpse into the future, and migraine epidemiology. Disease-a-month : DM, 2006, Volume: 52, Issue:10 Topics: Benzamides; Benzopyrans; Calcitonin Gene-Related Peptide; Drug Therapy, Combination; Ergotamine; Global Health; Humans; Incidence; Indans; Migraine Disorders; Piperazines; Prevalence; Prospective Studies; Quinazolines; Randomized Controlled Trials as Topic; Spiro Compounds; Sumatriptan; Treatment Outcome; United States; Vasoconstrictor Agents; Vasodilator Agents	2006
Emerging migraine treatments and drug targets. Trends in pharmacological sciences, 2011, Volume: 32, Issue:6 Topics: Benzamides; Benzopyrans; Botulinum Toxins, Type A; Calcitonin Gene-Related Peptide Receptor Antagonists; Drug Design; Drug Therapy; Humans; Migraine Disorders; Nervous System; Nitric Oxide; Serotonin 5-HT1 Receptor Agonists; Sumatriptan	2011

Article

Year

Migraine headaches: a historical prospective, a glimpse into the future, and migraine epidemiology.

Disease-a-month : DM, 2006, Volume: 52, Issue:10

Topics: Benzamides; Benzopyrans; Calcitonin Gene-Related Peptide; Drug Therapy, Combination; Ergotamine; Global Health; Humans; Incidence; Indans; Migraine Disorders; Piperazines; Prevalence; Prospective Studies; Quinazolines; Randomized Controlled Trials as Topic; Spiro Compounds; Sumatriptan; Treatment Outcome; United States; Vasoconstrictor Agents; Vasodilator Agents

2006

Emerging migraine treatments and drug targets.

Trends in pharmacological sciences, 2011, Volume: 32, Issue:6

Topics: Benzamides; Benzopyrans; Botulinum Toxins, Type A; Calcitonin Gene-Related Peptide Receptor Antagonists; Drug Design; Drug Therapy; Humans; Migraine Disorders; Nervous System; Nitric Oxide; Serotonin 5-HT1 Receptor Agonists; Sumatriptan

2011

Trials

1 trial(s) available for sumatriptan and tonabersat

Article	Year
Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study. Cephalalgia : an international journal of headache, 2009, Volume: 29 Suppl 2 Topics: Adult; Analgesics; Benzamides; Benzopyrans; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Safety; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome	2009

Article

Year

Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study.

Cephalalgia : an international journal of headache, 2009, Volume: 29 Suppl 2

Topics: Adult; Analgesics; Benzamides; Benzopyrans; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Safety; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome

2009

Other Studies

5 other study(ies) available for sumatriptan and tonabersat

Article	Year
Identification of (-)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)- 3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent. Bioorganic & medicinal chemistry letters, 1999, Jan-18, Volume: 9, Issue:2 Topics: Animals; Benzamides; Benzopyrans; Dose-Response Relationship, Drug; Methylcellulose; Mice; Migraine Disorders; Rats; Seizures; Sumatriptan; Temperature; Time Factors	1999
The potential anti-migraine compound SB-220453 does not contract human isolated blood vessels or myocardium; a comparison with sumatriptan. Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:6 Topics: Adult; Aged; Analgesics; Benzamides; Benzopyrans; Coronary Vessels; Drug Evaluation, Preclinical; Female; Heart Atria; Heart Ventricles; Humans; Male; Meningeal Arteries; Middle Aged; Myocardial Contraction; Norepinephrine; Saphenous Vein; Sumatriptan; Vasoconstriction	2000
Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan. Brain research, 2001, Feb-09, Volume: 891, Issue:1-2 Topics: Analgesics; Animals; Benzamides; Benzopyrans; Brain Stem; Cerebral Cortex; Cortical Spreading Depression; Cyclic GMP; Male; Migraine Disorders; Nitric Oxide; Nitric Oxide Synthase; Potassium Chloride; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sumatriptan; Vasoconstrictor Agents	2001
Diffusion-weighted MRI used to detect in vivo modulation of cortical spreading depression: comparison of sumatriptan and tonabersat. Experimental neurology, 2001, Volume: 172, Issue:2 Topics: Animals; Anticonvulsants; Benzamides; Benzopyrans; Cats; Cerebral Cortex; Cortical Spreading Depression; Diffusion; Electroencephalography; Feasibility Studies; Female; Magnetic Resonance Imaging; Potassium Chloride; Serotonin Receptor Agonists; Sumatriptan; Time Factors	2001
A delayed class of BOLD waveforms associated with spreading depression in the feline cerebral cortex can be detected and characterised using independent component analysis (ICA). Magnetic resonance imaging, 2003, Volume: 21, Issue:9 Topics: Animals; Anticonvulsants; Artifacts; Benzamides; Benzopyrans; Cats; Cerebral Cortex; Cerebrovascular Circulation; Cortical Spreading Depression; Female; Magnetic Resonance Imaging; Serotonin 5-HT1 Receptor Agonists; Sumatriptan	2003